CME
CME Group Inc
CME Group Inc historical holders
total: 13
Viking Global Investors CME Group Inc transactions over time
- Total transactions:
- 12
- New positions:
- 5
- Sold out:
- 4
- Added:
- 2
- Reduced:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Ole Andreas Halvorsen has been an institutional investor in CME Group Inc (CME) since 2014 Q1. According to 2026 Q2 report, Ole Andreas Halvorsen holds 152,980 shares with a market value of roughly $33.78M representing 0.10% of their equity portfolio. The fund/company first acquired CME in 2014 Q1, initially purchasing 558,300 shares. Ole Andreas Halvorsen later completely sold out the position and reinvested in CME again in 2026 Q2. Since the initial investment, Viking Global Investors has made 11 more transactions in this position.
Does Ole Andreas Halvorsen still hold CME?
Yes, Ole Andreas Halvorsen continues to hold CME Group Inc (CME). According to their 2026 Q2 report, they maintain a position of 152,980 shares valued at approximately $33.78M, representing 0.10% of their equity portfolio.
When did Ole Andreas Halvorsen first invest in CME?
Ole Andreas Halvorsen first invested in CME Group Inc (CME) in 2014 Q1 at the reported quarter-end price of $74.02 per share, acquiring 558,300 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for CME?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for CME Group Inc (CME) is approximately $220.83 per share. This represents their average reported price* across all buy transactions.
Has Ole Andreas Halvorsen reinvested in CME after selling?
Yes, Ole Andreas Halvorsen has shown renewed interest in CME Group Inc (CME). After completely selling their position, they reinitiated an investment in 2026 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $220.83
CME transactions history by Viking Global Investors
12 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.10%
|
152,980
|
$220.83
|
$33,782,573
|
new
|
+0.1%
|
|
2025 Q3
|
0.00%
|
0
|
$275.62
|
|
-100% (-597,374)
|
-0.48%
|
|
2025 Q2
|
0.48%
|
597,374
|
$275.62
|
$164,648,222
|
new
|
+0.48%
|
|
2022 Q4
|
0.00%
|
0
|
$177.13
|
|
-100% (-831,110)
|
-0.68%
|
|
2022 Q3
|
0.68%
|
831,110
|
$177.13
|
$147,215,000
|
+63.40% (+322,471)
|
+0.26%
|
|
2022 Q2
|
0.48%
|
508,639
|
$204.70
|
$104,118,000
|
new
|
+0.48%
|
|
2020 Q4
|
0.00%
|
$167.31
|
-100% (-2,316,366)
|
|||
|
2020 Q3
|
1.40%
|
$167.31
|
+379.90% (+1,833,687)
|
|||
|
2020 Q2
|
0.34%
|
$162.54
|
-71.64% (-1,219,294)
|
|||
|
2020 Q1
|
1.53%
|
$172.91
|
new
|
|||
|
2014 Q2
|
0.00%
|
$74.02
|
-100% (-558,300)
|
|||
|
2014 Q1
|
0.17%
|
$74.02
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.